首页> 外文OA文献 >An unbiased high-throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer

【2h】

An unbiased high-throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer

机译：一个无偏见的高通量药物筛选揭示胰腺癌最致命的分子亚型的潜在治疗性脆弱性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Chun-Hao Pan; Yuka Otsuka; BanuPriya Sridharan; Melissa Woo; Sruthi Babu; Cindy V. Leiton; Ji Dong K. Bai; David K. Chang; Andrew Biankin; Louis Scampavia; Timothy Spicer; Luisa F. Escobar-Hoyos; Kenneth R. Shroyer;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. An unbiased high‐throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer [J] . Chun‐Hao Pan, Yuka Otsuka, BanuPriya Sridharan, Molecular oncology. . 2020,第8期

机译：一个无偏见的高通量药物筛选揭示胰腺癌最致命的分子亚型的潜在治疗性脆弱性
2. A high-throughput drug screen identifies new therapeutic vulnerabilities in non-small cell lung cancers (NSCLC) with overexpression of the EMT-associated receptor tyrosine kinase AXL [J] . Cardnell R., Tong P., Giri U., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：高通量药物筛选可识别EMT相关受体酪氨酸激酶AXL过表达的非小细胞肺癌（NSCLC）的新治疗脆弱性
3. A high-throughput drug screen identifies new therapeutic vulnerabilities in non-small cell lung cancers (NSCLC) with overexpression of the EMT-associated receptor tyrosine kinase AXL [J] . Cardnell R., Tong P., Giri U., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：高通量药物筛网识别非小细胞肺癌（NSCLC）的新治疗漏洞，其具有EMT相关受体酪氨酸激酶AXL的过表达
4. Analysis of Human Pancreatic Tissue and Plasma Peptidome Reveals Potential Biomarkers for Pancreatic Cancer [C] . Kwasi Antwi, Galen Hostetter, Michael J. Demeure, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2009

机译：人类胰腺组织和血浆肽的分析显示出胰腺癌的潜在生物标志物
5. An RNA interference Lethality Screen of the Human Druggable Genome to Identify Molecular Vulnerabilities in Epithelial Ovarian Cancer. [D] . Sethi, Geetika. 2013

机译：人类可药物治疗基因组的RNA干扰致命性筛查，以鉴定上皮性卵巢癌中的分子脆弱性。
6. An unbiased high‐throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer [O] . Chun‐Hao Pan, Yuka Otsuka, BanuPriya Sridharan, 2020

机译：一个无偏见的高通量药物筛选揭示胰腺癌最致命的分子亚型的潜在治疗性脆弱性
7. Unsupervised clustering of multi-omics molecular layers reveals consensus molecular subtypes showing potential therapeutic opportunities for pancreatic cancer [O] . Sung Hwan LEE, Jiyeon PARK, Hye Jung CHO, 2021

机译：多OMICS分子层的无监督聚类揭示了胰腺癌潜在治疗机会的共有分子亚型

An unbiased high-throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer

著录项

引文网络

相似文献

相关主题

期刊订阅